Click here to view the original post by Healio Ophthalmology.
In addition to our own original articles, the Retina Consultant team expertly curates relevant news and research from leading publications.to provide our readers with a comprehensive view of the retina & ophthalmology landscape, Full credit belongs to the original authors and publication.
By clicking the link above, you will be leaving our site to view an article from its original source.
Sharpen your perspective. Get our weekly analysis of the news shaping the retina industry.
ORLANDO — In this video from the American Academy of Ophthalmology meeting, Stephen J. Kim, MD, discusses the toxicity of drugs such as Plaquenil.
“In this modern day, we should never be seeing patients who lose vision from Plaquenil (hydroxychloroquine sulfate, Sanofi) use,” Kim, professor of ophthalmology at Vanderbilt Eye Institute, told Healio.
He also discussed the impact of checkpoint inhibitors.
These drugs “can be highly effective, but they have side effects that are increasingly recognized,” Kim said, noting that they can cause uveitis, orbital inflammation and retinal inflammation.